Oaktree Specialty Lending Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Oaktree Specialty Lending Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $33.92M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $57.91M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $117.33M | Nov 18, 2025 |
| FY2023 | Dec 31, 2022 | $13.17M | Feb 7, 2023 |
| FY2024 | Sep 30, 2022 | $29.22M | Nov 19, 2024 |
| FY2023 | Dec 31, 2021 | $39.41M | Feb 7, 2023 |
| FY2023 | Sep 30, 2021 | $237.26M | Nov 14, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $228.37M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $19.08M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $228.76M | Nov 18, 2025 |
| FY2023 | Dec 31, 2022 | ($109.90M) | Feb 7, 2023 |
| FY2024 | Sep 30, 2022 | $22.40M | Nov 19, 2024 |
| FY2023 | Dec 31, 2021 | $23.19M | Feb 7, 2023 |
| FY2023 | Sep 30, 2021 | ($230.52M) | Nov 14, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.00B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $3.20B | Nov 18, 2025 |
| FY2024 | Sep 30, 2023 | $3.22B | Nov 19, 2024 |
| FY2023 | Dec 31, 2022 | $2.77B | Feb 7, 2023 |
| FY2023 | Sep 30, 2022 | $2.65B | Nov 14, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.54B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $1.71B | Nov 18, 2025 |
| FY2024 | Sep 30, 2023 | $1.70B | Nov 19, 2024 |
| FY2023 | Dec 31, 2022 | $1.57B | Feb 7, 2023 |
| FY2023 | Sep 30, 2022 | $1.40B | Nov 14, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.47B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $1.49B | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $1.52B | Nov 18, 2025 |
| FY2023 | Dec 31, 2022 | $1.20B | Feb 7, 2023 |
| FY2025 | Sep 30, 2022 | $1.25B | Nov 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.33B | Feb 7, 2023 |
| FY2024 | Sep 30, 2021 | $1.31B | Nov 19, 2024 |
| FY2023 | Sep 30, 2020 | $914.88M | Nov 14, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($885.14M) | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | ($777.46M) | Nov 18, 2025 |
| FY2024 | Sep 30, 2023 | ($651.34M) | Nov 19, 2024 |
| FY2023 | Dec 31, 2022 | ($628.28M) | Feb 7, 2023 |
| FY2023 | Sep 30, 2022 | ($582.77M) | Nov 14, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $79.63M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $63.97M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $136.45M | Nov 18, 2025 |
| FY2023 | Dec 31, 2022 | $17.38M | Feb 7, 2023 |
| FY2024 | Sep 30, 2022 | $23.53M | Nov 19, 2024 |
| FY2023 | Sep 30, 2021 | $29.33M | Nov 14, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.49B | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $1.64B | Nov 18, 2025 |
| FY2024 | Sep 30, 2023 | $1.60B | Nov 19, 2024 |
| FY2023 | Dec 31, 2022 | $1.46B | Feb 7, 2023 |
| FY2023 | Sep 30, 2022 | $1.30B | Nov 14, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | 1 | Nov 18, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Feb 7, 2023 |
| FY2024 | Sep 30, 2022 | 0 | Nov 19, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Feb 7, 2023 |
| FY2023 | Sep 30, 2021 | 4 | Nov 14, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | 1 | Nov 18, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Feb 7, 2023 |
| FY2024 | Sep 30, 2022 | 0 | Nov 19, 2024 |
| FY2023 | Dec 31, 2021 | 0 | Feb 7, 2023 |
| FY2023 | Sep 30, 2021 | 4 | Nov 14, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 88.09M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | 82.25M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | 77.23M | Nov 18, 2025 |
| FY2023 | Dec 31, 2022 | 61.22M | Feb 7, 2023 |
| FY2025 | Sep 30, 2022 | 61.13M | Nov 18, 2025 |
| FY2023 | Dec 31, 2021 | 60.16M | Feb 7, 2023 |
| FY2025 | Sep 30, 2021 | 60.12M | Nov 18, 2025 |
| FY2025 | Sep 30, 2020 | 46.99M | Nov 18, 2025 |
| FY2024 | Sep 30, 2019 | 46.99M | Nov 19, 2024 |
| FY2023 | Sep 30, 2018 | 46.99M | Nov 14, 2023 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $148.20M | Nov 18, 2025 |
| FY2025 | Sep 30, 2024 | $176.81M | Nov 18, 2025 |
| FY2025 | Sep 30, 2023 | $180.05M | Nov 18, 2025 |
| FY2023 | Dec 31, 2022 | $56.75M | Feb 7, 2023 |
| FY2024 | Sep 30, 2022 | $115.25M | Nov 19, 2024 |
| FY2023 | Dec 31, 2021 | $27.17M | Feb 7, 2023 |
| FY2023 | Sep 30, 2021 | $79.85M | Nov 14, 2023 |